Correlation of HML-2 expression to disease onset is well-supported, and suggests that provirus expression may be a useful biomarker for certain diseases, particularly breast cancer, where no useful diagnostic marker currently exists [83]. The gene discussed is CLEC10A; the disease is breast cancer.